BMI View: While geographic diversification and investment into the pharmaceutical and healthcare sectors of emerging economies like Gabon may be a favourable strategy for any multinational pharmaceutical company, it is vital that a company recognises both the rewards and the risks present in a market. To assess risks in Gabon’s healthcare sector, we have identified industry-specific dangers (such as the poor enforcement of intellectual property rights) and those emanating from the state’s political/ economic profile (such as stagnating oil production), that bring into question the likelihood of anticipated returns being realised over the assessed time period. Headline Expenditure Forecasts ? …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=113316.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/gabon-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.
No comments:
Post a Comment